โ Home
Stryker Corp
-14.9%
Healthcare & biotech / Orthopedics, medical and surgical, and neurotechnology and spine applications
โน๏ธ Info
๐งพ At a Glance ๐ Core Facts ๐๏ธ Products/Services โญ Ratings ๐งโ๐ผ Executives ๐ฌ My Comments๐ก Analytics
๐ Insights (1) ๐ข Company Q&A (663) ๐ ๏ธ Industry Q&A (164) ๐ Competitors ๐ Price Low ๐ Price Swings โก SWOT ๐๏ธ PEST ๐ Porter's Five Forces โจ Score Positive โ ๏ธ Risk Assessment ๐งฉ Segmentation ๐ ถ Google Links๐ Ratios
๐ฐ Margins ๐ Financial Ratios ๐ฑ Growth ๐ Enterprise Value ๐ Key Metrics ๐ต Dividends๐ง Tools
โ Due Diligence๐ข Press Releases
| Date | Press release |
|---|---|
| 2026-06-02 09:03:00 | Stryker Launches Tpx Hdยฎ Power Tool, Supporting Demanding Orthopaedic Procedures Portage, mich., june 2, 2026 /prnewswire/ -- stryker (nyse: syk), a global leader in medical technologies, announced the launch of its tpx hd, a premium small bone power tool designed to support performance, control and ergonomics in a wide range of challenging orthopaedic procedures such as total joint revisions, minimally invasive surgery and oral maxillofacial procedures. |
| 2026-05-26 02:10:00 | Stryker Launches Pangea Plating System And Completes First Case In Europe Amsterdam--(business wire)--stryker announced the european launch of its pangea plating system, a plating platform for the treatment of a wide range of fracture patterns. |
| 2026-05-19 05:30:00 | Biostar Capital-backed Amplitude Vascular Systemsโ $835m Acquisition By Stryker Reflects Strength Of Michiganโs Medtech Ecosystem Charlevoix, mich.--(business wire)--biostar capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-fda exit of amplitude vascular systems, inc. (avs), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (ivl) platform to treat calcified peripheral arterial disease. upon acquiring avs for up to $835 million, stryker (nyse:syk), a global leader in medical technologies, called the deal a milestone in. |
| 2026-05-18 16:15:00 | Avs, Now Part Of Stryker, Enrolls First Patient In First-in-human Coronary Intravascular Lithotripsy Study Boston--(business wire)--amplitude vascular systems (avs), a medical device company recently acquired by stryker and focused on treating severely calcified arterial disease, today announced the enrollment of the first patient in its first-in-human (fih) study for pulsatile intravascular lithotripsy (pivl) therapy in a coronary indication. the power cad i study will evaluate the feasibility of the pulse ivlโข system for the treatment of patients with moderate to severely calcified coronary arteri. |
| 2026-05-07 16:05:00 | Stryker Completes Acquisition Of Amplitude Vascular Systems To Add Next-generation Ivl Technology To Peripheral Vascular Portfolio Portage, michigan, may 07, 2026 (globe newswire) -- stryker (nyse:syk announced that it has completed the acquisition of amplitude vascular systems, inc. (avs), a privately held medical technology company developing a next-generation intravascular lithotripsy (ivl) platform designed to treat complex peripheral arterial disease. โthis acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease,โ said kevin lobo, chair and ceo, stryker. |
| 2026-05-07 08:00:00 |
|
| 2026-05-01 08:00:00 |
|
| 2026-04-30 16:05:00 |
|
| 2026-04-30 09:03:00 |
|
| 2026-04-24 08:50:00 |
|
| 2026-04-22 12:16:00 |
|
| 2026-04-16 08:41:00 |
|
| 2026-04-13 08:00:00 |
|
| 2026-04-01 08:00:00 |
|
| 2026-03-31 08:00:00 |
|
๐ฐ Browse additional press releases for Stryker Corp!
Sign up for free or log in๐ Discover "The Checklist Value Investor โ A Smarter Way to Pick Stocks" โ free eBook!